annual FCF:
-$231.11M-$85.74M(-58.98%)Summary
- As of today (July 1, 2025), AKRO annual free cash flow is -$231.11 million, with the most recent change of -$85.74 million (-58.98%) on December 31, 2024.
- During the last 3 years, AKRO annual FCF has fallen by -$151.43 million (-190.04%).
- AKRO annual FCF is now -2301.10% below its all-time high of -$9.63 million, reached on December 31, 2018.
Performance
AKRO Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$67.66M-$574.00K(-0.86%)Summary
- As of today (July 1, 2025), AKRO quarterly free cash flow is -$67.66 million, with the most recent change of -$574.00 thousand (-0.86%) on March 31, 2025.
- Over the past year, AKRO quarterly FCF has dropped by -$32.52 million (-92.56%).
- AKRO quarterly FCF is now -19918.93% below its all-time high of -$338.00 thousand, reached on March 31, 2018.
Performance
AKRO quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$263.63M-$32.52M(-14.07%)Summary
- As of today (July 1, 2025), AKRO TTM free cash flow is -$263.63 million, with the most recent change of -$32.52 million (-14.07%) on March 31, 2025.
- Over the past year, AKRO TTM FCF has dropped by -$107.75 million (-69.13%).
- AKRO TTM FCF is now -77897.04% below its all-time high of -$338.00 thousand, reached on March 31, 2018.
Performance
AKRO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
AKRO Free cash flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -59.0% | -92.6% | -69.1% |
3 y3 years | -190.0% | -195.8% | -213.1% |
5 y5 years | -548.7% | -497.9% | -348.6% |
AKRO Free cash flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -190.0% | at low | -246.8% | +3.9% | -215.0% | at low |
5 y | 5-year | -548.7% | at low | -395.7% | +3.9% | -348.6% | at low |
alltime | all time | -2301.1% | at low | <-9999.0% | +3.9% | <-9999.0% | at low |
AKRO Free cash flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$67.66M(+0.9%) | -$263.63M(+14.1%) |
Dec 2024 | -$231.11M(+59.0%) | -$67.09M(-4.7%) | -$231.11M(+8.7%) |
Sep 2024 | - | -$70.42M(+20.5%) | -$212.64M(+10.8%) |
Jun 2024 | - | -$58.45M(+66.3%) | -$191.94M(+23.1%) |
Mar 2024 | - | -$35.14M(-27.7%) | -$155.88M(+7.2%) |
Dec 2023 | -$145.37M(+57.1%) | -$48.63M(-2.2%) | -$145.37M(+18.9%) |
Sep 2023 | - | -$49.72M(+122.1%) | -$122.25M(+25.8%) |
Jun 2023 | - | -$22.39M(-9.1%) | -$97.15M(+3.1%) |
Mar 2023 | - | -$24.63M(-3.4%) | -$94.27M(+1.9%) |
Dec 2022 | -$92.52M(+16.1%) | -$25.51M(+3.6%) | -$92.52M(-1.3%) |
Sep 2022 | - | -$24.62M(+26.2%) | -$93.70M(+12.0%) |
Jun 2022 | - | -$19.51M(-14.7%) | -$83.69M(-0.6%) |
Mar 2022 | - | -$22.88M(-14.3%) | -$84.21M(+5.7%) |
Dec 2021 | -$79.68M | -$26.70M(+82.8%) | -$79.68M(+4.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2021 | - | -$14.61M(-27.1%) | -$76.39M(+1.3%) |
Jun 2021 | - | -$20.03M(+9.2%) | -$75.43M(-3.3%) |
Mar 2021 | - | -$18.35M(-21.6%) | -$77.98M(+9.9%) |
Dec 2020 | -$70.95M(+99.2%) | -$23.40M(+71.4%) | -$70.95M(+19.8%) |
Sep 2020 | - | -$13.65M(-39.6%) | -$59.20M(+0.7%) |
Jun 2020 | - | -$22.58M(+99.6%) | -$58.76M(+41.6%) |
Mar 2020 | - | -$11.32M(-2.9%) | -$41.50M(+16.5%) |
Dec 2019 | -$35.63M(+270.2%) | -$11.65M(-11.8%) | -$35.63M(+36.7%) |
Sep 2019 | - | -$13.21M(+148.3%) | -$26.05M(+76.0%) |
Jun 2019 | - | -$5.32M(-2.2%) | -$14.80M(+0.5%) |
Mar 2019 | - | -$5.44M(+162.4%) | -$14.73M(+53.0%) |
Dec 2018 | -$9.63M | -$2.08M(+5.8%) | -$9.63M(+27.5%) |
Sep 2018 | - | -$1.96M(-62.7%) | -$7.55M(+35.1%) |
Jun 2018 | - | -$5.25M(+1453.6%) | -$5.59M(+1553.6%) |
Mar 2018 | - | -$338.00K | -$338.00K |
FAQ
- What is Akero Therapeutics annual free cash flow?
- What is the all time high annual FCF for Akero Therapeutics?
- What is Akero Therapeutics annual FCF year-on-year change?
- What is Akero Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Akero Therapeutics?
- What is Akero Therapeutics quarterly FCF year-on-year change?
- What is Akero Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Akero Therapeutics?
- What is Akero Therapeutics TTM FCF year-on-year change?
What is Akero Therapeutics annual free cash flow?
The current annual FCF of AKRO is -$231.11M
What is the all time high annual FCF for Akero Therapeutics?
Akero Therapeutics all-time high annual free cash flow is -$9.63M
What is Akero Therapeutics annual FCF year-on-year change?
Over the past year, AKRO annual free cash flow has changed by -$85.74M (-58.98%)
What is Akero Therapeutics quarterly free cash flow?
The current quarterly FCF of AKRO is -$67.66M
What is the all time high quarterly FCF for Akero Therapeutics?
Akero Therapeutics all-time high quarterly free cash flow is -$338.00K
What is Akero Therapeutics quarterly FCF year-on-year change?
Over the past year, AKRO quarterly free cash flow has changed by -$32.52M (-92.56%)
What is Akero Therapeutics TTM free cash flow?
The current TTM FCF of AKRO is -$263.63M
What is the all time high TTM FCF for Akero Therapeutics?
Akero Therapeutics all-time high TTM free cash flow is -$338.00K
What is Akero Therapeutics TTM FCF year-on-year change?
Over the past year, AKRO TTM free cash flow has changed by -$107.75M (-69.13%)